February 12th, 2010
Podcast 74: How two SSRIs apparently interfere with tamoxifen therapy.
Podcast: Play in new window | Download
Subscribe: RSS
We talk with Dr. Catherine Kelly about her study in BMJ showing serious interference of some SSRIs with tamoxifen therapy in breast cancer. The study was conducted using Canadian provincial databases.
Reach us at 1-617-440-4374 or by email to jelia@jwatch.org.
Interview article:
Medical news links:
- Back pain guidelines
- Inflammatory bowel disease and venous thromboembolism
- Automated calling systems
Categories: antidepressants, Audio, breast cancer, SSRIs, tamoxifen, Uncategorized
Tags: automated phone calling systems, back pain, breast cancer, Catherine Kelly, CYP2D6, drug metabolism, fluoxetine, inflammatory bowel disease, paroxetine, screening, SSRIs, tamoxifen, venous thromboembolism
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
- Podcast 261: COVID-19 as a medical disaster (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin